Intramedullary Nails Market Report 2024

This Intramedullary Nails market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The intramedullary nails market size has grown strongly in recent years. It will grow from $0.81 billion in 2023 to $0.87 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period is attributed to the increase in the number of fractures, the greater susceptibility of the aging population, advancements in surgical methods and technology, a shift towards minimally invasive surgical techniques, and improvements in design and materials.

The intramedullary nails market size is expected to see strong growth in the next few years. It will grow to $1.16 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period is attributed to the rise in sports-related injuries, better access to surgical procedures, increasing awareness among healthcare professionals, and a rise in outpatient surgical procedures. Key trends during this period include the adoption of locking nails, the development and use of bioabsorbable nails, a trend towards personalized medicine, the growth of emerging economies due to improved healthcare access, and the integration of smart technologies in orthopedic devices.

The increasing incidence of bone fractures is expected to drive the growth of the intramedullary nail market. Bone fractures are medical conditions characterized by partial or complete breaks in the continuity of a bone. These fractures occur when the force applied to a bone exceeds its strength, causing it to crack or break. Additionally, osteoporosis, a condition where bones become thin, weak, and brittle due to loss of bone density, further increases susceptibility to fractures. Intramedullary nails provide internal fixation by being inserted into the medullary canal of long bones, which is crucial for aligning fractured bones and facilitating proper healing. For instance, in February 2023, the International Osteoporosis Foundation, a Switzerland-based non-governmental organization, reported that up to 37 million fragility fractures occur globally each year in individuals over 55, equating to 70 fractures per minute. Furthermore, annual fractures are expected to rise from 1.9 million to 3.2 million (68%) from 2018 to 2040, with related costs increasing from $57 billion to over $95 billion annually. Consequently, the growing prevalence of bone fractures is a significant driver of the intramedullary nails market.

Key players in the intramedullary nail market are focusing on developing advanced products, such as hip fracture nailing systems, to offer improved stability, surgical outcomes, and features for minimally invasive procedures. A hip fracture nailing system is a specialized surgical device used to treat fractures of the hip, particularly those in the proximal femur, such as intertrochanteric or subtrochanteric fractures. For example, in September 2022, Stryker Corporation, a US-based medical technology company, introduced the Gamma4 Hip Fracture Nailing System, the latest generation of its intramedullary nailing system designed for hip fractures. The Gamma4 System is suitable for both stable and unstable hip fractures, including those in the intracapsular, trochanteric, subtrochanteric, and femoral shaft regions. The system features a SOMA-designed nail with length-dependent RoC for long nails, a proximal body shortened by 5mm, a chamfered distal tip, and a pre-inserted and cannulated set screw.

In July 2022, Acumed LLC, a US-based medical device manufacturer, acquired ExsoMed Corporation for an undisclosed amount. This acquisition is part of Acumed's strategy to address the growing demand for minimally invasive surgical solutions and to provide customizable options for optimal patient care. ExsoMed Corporation is a US-based manufacturer specializing in intramedullary rods.

Major companies operating in the intramedullary nails market are Johnson & Johnson, Medtronic plc, Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Integra LifeSciences Holdings Corporation, NuVasive Inc., Globus Medical Inc., Wright Medical Group N.V., Orthofix Medical Inc., Aesculap Inc., Paragon 28 Inc., Acumed LLC, Alphatec Spine Inc., OsteoMed LLC, Merete Medical GmbH, Skeletal Dynamics LLC, Centinel Spine Inc., Teijin Nakashima Medical Co. Ltd., MICROMED Medizintechnik GmbH, Orthopaedic Implant Company, Orthomed S.A.S., Novastep Inc., BioMedtrix LLC.

North America was the largest region in the intramedullary nails market in 2023. The regions covered in the intramedullary nails market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the intramedullary nails market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Intramedullary nails (IM nails) are medical devices used mainly in orthopedic surgery to treat fractures of long bones, such as the femur (thigh bone), tibia (shin bone), and humerus (upper arm bone). These nails are inserted into the medullary canal, the central cavity of long bones, to provide internal stabilization and support bone healing. The primary function of intramedullary nails is to stabilize fractured bones and assist in their proper alignment during the healing process.

The main types of intramedullary nails include long gamma nails (LGN), trochanteric femoral nails (TFN), and intertrochanteric/subtrochanteric nails (ITST), among others. Long gamma nails are designed for the stabilization and fixation of long bone fractures, especially in the femur. They are made from materials such as titanium alloys and stainless steel. These nails are used for various applications, including femoral and tibial fractures, and are employed by different end users such as hospitals, ambulatory surgical centers, specialty and orthopedic clinics, among others.

The intramedullary nails market research report is one of a series of new reports that provides intramedullary nails market statistics, including intramedullary nails industry global market size, regional shares, competitors with a intramedullary nails market share, detailed intramedullary nails market segments, market trends, and opportunities, and any further data you may need to thrive in the intramedullary nails industry. This intramedullary nails market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The intramedullary nails market consists of sales of femoral nails, tibial nails, and specialized nails. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.